Kishor Mayekar

Array ( [id] => 5851758 [patent_doc_number] => 20060234949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Adduct of topiramate and tramadol hydrochloride and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/514739 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3401 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234949.pdf [firstpage_image] =>[orig_patent_app_number] => 10514739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7616991 [patent_doc_number] => 06946450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-20 [patent_title] => 'β-L-2′-deoxy-nucleosides for the treatment of hepatitis B' [patent_app_type] => utility [patent_app_number] => 10/437802 [patent_app_country] => US [patent_app_date] => 2003-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18002 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/946/06946450.pdf [firstpage_image] =>[orig_patent_app_number] => 10437802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664753 [patent_doc_number] => 20030204080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Methods for producing nucleoside derivatives and intermediates therefor' [patent_app_type] => new [patent_app_number] => 10/435374 [patent_app_country] => US [patent_app_date] => 2003-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9463 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20030204080.pdf [firstpage_image] =>[orig_patent_app_number] => 10435374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206860 [patent_doc_number] => 20040087540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Combinatorial library synthesis and pharmaceutically active compounds produced thereby' [patent_app_type] => new [patent_app_number] => 10/424594 [patent_app_country] => US [patent_app_date] => 2003-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8079 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087540.pdf [firstpage_image] =>[orig_patent_app_number] => 10424594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436216 [patent_doc_number] => 20090170803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'ADJUNCTIVE TREATMENT OF BIOLOGICAL DISEASES' [patent_app_type] => utility [patent_app_number] => 10/412726 [patent_app_country] => US [patent_app_date] => 2003-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25714 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170803.pdf [firstpage_image] =>[orig_patent_app_number] => 10412726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805591 [patent_doc_number] => 20030232985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Succinoylamino heterocycles as inhibitors of a beta protein production' [patent_app_type] => new [patent_app_number] => 10/409960 [patent_app_country] => US [patent_app_date] => 2003-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28145 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232985.pdf [firstpage_image] =>[orig_patent_app_number] => 10409960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 545148 [patent_doc_number] => 07169916 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-30 [patent_title] => 'Chloral-free DCA in oligonucleotide synthesis' [patent_app_type] => utility [patent_app_number] => 10/403692 [patent_app_country] => US [patent_app_date] => 2003-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16893 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/169/07169916.pdf [firstpage_image] =>[orig_patent_app_number] => 10403692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 888189 [patent_doc_number] => 07348315 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-25 [patent_title] => 'Methods of treating heart failure with modified ATP, ADP and AMP compounds' [patent_app_type] => utility [patent_app_number] => 10/396200 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 10040 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/348/07348315.pdf [firstpage_image] =>[orig_patent_app_number] => 10396200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 274271 [patent_doc_number] => 07560435 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-14 [patent_title] => 'Therapeutic use of riboside of 5-aminoimidazole-4-carboxamide (acadesine)' [patent_app_type] => utility [patent_app_number] => 10/508305 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2779 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560435.pdf [firstpage_image] =>[orig_patent_app_number] => 10508305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1180362 [patent_doc_number] => 06740644 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-25 [patent_title] => 'Chemical compounds' [patent_app_type] => B2 [patent_app_number] => 10/373064 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9418 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 286 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/740/06740644.pdf [firstpage_image] =>[orig_patent_app_number] => 10373064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142433 [patent_doc_number] => 20070004649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Anti-influenza virus compound comprising biflavonoid-sialic acid glycoside' [patent_app_type] => utility [patent_app_number] => 10/547125 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25739 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004649.pdf [firstpage_image] =>[orig_patent_app_number] => 10547125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1014814 [patent_doc_number] => 06894158 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-17 [patent_title] => 'Methods of producing phosphitylated compounds' [patent_app_type] => utility [patent_app_number] => 10/373336 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7084 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/894/06894158.pdf [firstpage_image] =>[orig_patent_app_number] => 10373336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 616459 [patent_doc_number] => 07144871 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-05 [patent_title] => 'Partial and full agonists of A1 adenosine receptors' [patent_app_type] => utility [patent_app_number] => 10/370679 [patent_app_country] => US [patent_app_date] => 2003-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14754 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/144/07144871.pdf [firstpage_image] =>[orig_patent_app_number] => 10370679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136067 [patent_doc_number] => 20040043959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Combination therapies for treating methylthioadenosine phosphorylase deficient cells' [patent_app_type] => new [patent_app_number] => 10/367366 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 43058 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043959.pdf [firstpage_image] =>[orig_patent_app_number] => 10367366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020060 [patent_doc_number] => 20050222079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Preparation containing folic acid, vitamin b6, and vitamin b12, and use thereof' [patent_app_type] => utility [patent_app_number] => 10/503592 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4620 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222079.pdf [firstpage_image] =>[orig_patent_app_number] => 10503592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1077103 [patent_doc_number] => 07615619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'Nucleoside analogues and oligonucleotide derivative comprising nucleotide analogue thereof' [patent_app_type] => utility [patent_app_number] => 10/504165 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16271 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615619.pdf [firstpage_image] =>[orig_patent_app_number] => 10504165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6913183 [patent_doc_number] => 20050176941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Nucleoside analogues whose sugar moieties are bound in s-form and oligonucleotide derivatives comprising nucleotide analogues thereof' [patent_app_type] => utility [patent_app_number] => 10/504479 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23871 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176941.pdf [firstpage_image] =>[orig_patent_app_number] => 10504479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6684199 [patent_doc_number] => 20030120063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Method for deblocking of labeled oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/365644 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2668 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20030120063.pdf [firstpage_image] =>[orig_patent_app_number] => 10365644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 691045 [patent_doc_number] => 07074805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor' [patent_app_type] => utility [patent_app_number] => 10/364210 [patent_app_country] => US [patent_app_date] => 2003-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30513 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074805.pdf [firstpage_image] =>[orig_patent_app_number] => 10364210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678423 [patent_doc_number] => 20030228564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Nitric oxide in a pathogen inactivation process' [patent_app_type] => new [patent_app_number] => 10/364661 [patent_app_country] => US [patent_app_date] => 2003-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 24831 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228564.pdf [firstpage_image] =>[orig_patent_app_number] => 10364661 [rel_patent_id] =>[rel_patent_doc_number] =>)